Federal contract award
75N93020F00003
PRE-CLINICAL MODELS OF INFECTIOUS DISEASES; TASK C12 LYMPHATIC FILARIASIS VACCINE (LFGUARD) EFFICACY TRIAL IN DOGS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541711 |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | HHSN272201700035I |
| Set-aside | Not reported |
| Pricing type | COST NO FEE |
| Obligations | $357.0K |
| Current contract value | $357.0K |
| Potential contract value / ceiling | $357.0K |
| Start date | Sep 16, 2020 |
| Current end date | Jan 15, 2022 |
| Potential end date | Apr 27, 2022 |
| Latest award activity | Sep 23, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 23, 2025 | P00002 | $-14.0K | PRE-CLINICAL MODELS OF INFECTIOUS DISEASES; TASK C12 LYMPHATIC FILARIASIS VACCINE (LFGUARD) EFFICACY TRIAL IN DOGS |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.